ICICI Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund

As of Jun 2026, ICICI Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund — an institution tracked through public shareholding filings — disclosed 10 holdings in Indian listed companies worth ₹1,864 crore. The same holdings-at-filing-value basis put it at ₹1,217 crore in Mar 2026 (+53.2%). Solomo carries these filings back to Sep 2018.

Largest disclosed positions in Jun 2026: Thyrocare Technologies Ltd (THYROCARE — 5.57% of the company, ₹492 crore); Blue Jet Healthcare Ltd (BLUEJET — 3.83% of the company, ₹403 crore); Akums Drugs & Pharmaceuticals Ltd (AKUMS — 3.14% of the company, ₹310 crore); Alembic Pharmaceuticals Ltd (APLLTD — 1.38% of the company, ₹223 crore); Entero Healthcare Solutions Ltd (ENTERO — 2.16% of the company, ₹114 crore). Those 5 account for 83% of the disclosed value.

Changes in the Jun 2026 filings: newly disclosed — Entero Healthcare Solutions Ltd. Stake raised in Blue Jet Healthcare Ltd (+2.64 pp), Alembic Pharmaceuticals Ltd (+0.26 pp), Aarti Drugs Ltd (+0.03 pp). Stake reduced in Windlas Biotech Ltd (−1.77 pp), Akums Drugs & Pharmaceuticals Ltd (−1.42 pp), Laxmi Dental Ltd (−0.31 pp). No longer disclosed after the previous quarter: Senores Pharmaceuticals Ltd — which can mean a sale, a stake falling below the 1% disclosure line, or that name not filing this quarter.